Premium Protein Quality HumanZyme's proteins are expressed in human cells with authentic folding, glycosylation, disulfide bonds, and subunit assembly, produced in chemically defined, animal-product-free and Xeno-free media. This quality can translate into higher specific activity and stability, making their recombinant human cytokines and growth factors appealing to stem cell researchers and drug discovery teams who need functionally relevant proteins. Position as a premium supply option to justify value-based pricing and renewals.

Scalable Cost Advantage The HEK293-based platform enables production from small to large scales in a cost-effective way, supporting researchers from early assay development to larger preclinical programs without switching suppliers. This creates opportunities for multi-year supply agreements, bundled orders, and volume discounts with academic labs, startups, and CROs focused on human proteins.

Channel Opportunity Historical acquisition by Proteintech indicates access to broader distribution and marketing channels. Leverage potential partnerships or co-branding through Proteintech’s network to expand geographic reach and credibility, targeting institutions and companies that prefer established distributors for bioscience reagents.

Interferon Focus Active expansion of the HumanKine interferon portfolio (IFN-beta and IFN-gamma) demonstrates capability to develop and supply key cytokines for immunology, antiviral, and stem cell assays. Use this as a foothold to upsell additional cytokines and growth factors, cross-sell to existing customers, and approach labs building cytokine panels.

CRM Driven With Salesforce in place, there is an opportunity to run data-driven sales campaigns, build account-based outreach to academia, biotech startups, and CROs, and track lifecycle engagement for repeat orders of human proteins. Target customers with defined-media compatible products and high-activity proteins.